Examkin

Soru

Zorluk: ZorDiagnostic Workup and Test Sequencing

During a routine health maintenance examination, a physician detects an asymmetric neck swelling in a previously healthy 48-year-old female. The patient reports a 3-kg (6.6-lb) unintentional weight loss over the past two months and describes intermittent episodes of a 'racing heart.' Vital signs show a heart rate of 98/min and a blood pressure of 128/82 mmHg. Physical examination reveals a firm, mobile, 2.5-cm mass in the right anterior neck that moves with swallowing. No cervical lymphadenopathy is appreciated. Laboratory evaluation demonstrates a thyroid-stimulating hormone (TSH) level of 0.08 µU/mL (normal: 0.4–4.0 µU/mL) and a free thyroxine (T4) level of 2.1 ng/dL (normal: 0.8–1.8 ng/dL). A comprehensive neck ultrasound identifies a 2.6-cm solid, mildly hypoechoic nodule in the right thyroid lobe with increased central vascularity. Which of the following is the most appropriate next step in the diagnostic evaluation of this patient's condition?

  1. Radionuclide thyroid scintigraphyCevap
  2. B
    Fine-needle aspiration biopsy of the nodule
  3. C
    Computed tomography of the neck with intravenous contrast
  4. D
    Measurement of serum calcitonin concentration
  5. E
    Repeat neck ultrasound and thyroid function tests in 6 months

Cevap

Radionuclide thyroid scintigraphy is the correct next step to evaluate a thyroid nodule in the setting of a suppressed TSH.
The correct sequence for evaluating a newly discovered thyroid nodule begins with a serum TSH and a thyroid ultrasound. The TSH level dictates the subsequent pathway. If the TSH is normal or elevated, the next step is fine-needle aspiration (FNA) based on size and ultrasound characteristics. However, if the TSH is subnormal (suppressed), as seen in this patient, the next step must be radionuclide thyroid scintigraphy (using Iodine-123 or Technetium-99m). This test determines if the nodule is hyperfunctioning ('hot'), isofunctioning ('warm'), or nonfunctioning ('cold'). Hyperfunctioning nodules are virtually always benign (e.g., toxic adenoma) and do not require FNA, whereas 'cold' nodules have a higher risk of malignancy and warrant subsequent FNA.

Adım Adım Çözüm

1
Analyze the patient's initial laboratory results in the context of the physical examination.
The patient has a palpable 2.5-cm thyroid nodule associated with biochemical and clinical hyperthyroidism (suppressed TSH, elevated free T4, weight loss, palpitations).
Establishing the biochemical functional status of the thyroid is the critical first branching point in the evaluation of any new thyroid nodule.
2
Evaluate the ultrasound findings alongside the laboratory results.
The ultrasound confirms a nodule larger than 1 cm with suspicious features (hypoechoic, solid, central vascularity).
Ultrasound characterizes the size and anatomy of the nodule, helping to stratify malignancy risk.
3
Apply the standard diagnostic sequencing algorithm for thyroid nodules.
Because the TSH is subnormal (suppressed), the algorithm dictates that a radionuclide thyroid scan must be performed next, regardless of how suspicious the ultrasound features appear.
A hyperfunctioning ('hot') nodule is almost never malignant and therefore does not require a fine-needle aspiration. Proceeding straight to biopsy skips this vital screening step and subjects the patient to an unnecessary invasive procedure.

Anahtar Kavram

The initial evaluation of a thyroid nodule requires measuring TSH; if TSH is suppressed, a radionuclide thyroid scan is the required next step to differentiate a benign hyperfunctioning nodule from a nonfunctioning nodule.
Bu soruyu puanla

Konular

Diagnostic Workup and Test Sequencing

Bu konudan daha fazla soru